TEVA, a first in biotechnology
Teva Pharmaceutical Industries is an Israeli pharmaceutical company, specializing in generic drugs and active ingredients.
It is one of the 25 largest pharmaceutical companies in the world and the largest producer of generic drugs.
As part of its Genesis investment in Germany, TEVA awards Pierre Guerin a major contract for a large-scale cell culture facility. This consists in the supply of 2 cell culture and harvesting lines, with 15 bioreactors up to 15,000L, 8 media and harvesting tanks up to 20,000L and filtration skids.
The facilities are intended for the GMP manufacture of biosimilars, mainly monoclonal antibodies.
.
